UAE Drug Regulator Orders Recall Of Schwarz Pharma Heart Drug
This article was originally published in PharmAsia News
The United Arab Emirates ordered a recall of Germany-based Schwarz Pharma's Nitrocine (glyceryl trinitrate) for treating heart and blood-pressure problems on grounds it may contain impurities.
You may also be interested in...
CMS head Brooks-LaSure says agency is making progress in staffing the drug pricing control programs established by the Inflation Reduction Act. Medicare Center deputy director Cheri Rice will be its acting director under just-unveiled management structure.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Proposed rule introduces two exemptions agency would allow from needing IND clearance for clinical investigations to evaluate food, supplements or cosmetics. Both begin with basic requirement of trial not intended to support drug development plan or labeling change that would make a food, dietary ingredient or cosmetic an unlawfully marketed drug.